2025 Cosmetic Trends: The Truth About Facelifts, Threads & Fat Transfer | Dr. Miguel Mascaro

Product/Service Reviewed

This video is not a single consumer product review. It’s a clinician discussion-style rundown of cosmetic facial procedures and “2025 trends,” including:

• Facelifts (timing and approach)
• Fat transfer
• Bio-stimulators (e.g., Sculptra; “Renova/Rejuvel/Renuva” mentioned)
• Threads
• Lasers
• Softwave
• Chin implants
• Other injectables

---

Key Points (Unique)

1. Facelift/aging strategy: “maintenance over waiting”

   • Emphasizes you shouldn’t wait until “the house is completely on fire.”
   • “Little things over time make a big difference.”
   • Decisions should consider not only how someone looks now, but where they want to be in 3–10 years.

2. Facelift timing and the “sweet spot”

   • Suggests the best facelift results often occur when patients are younger, partly because bone density declines with age.
   • Notes women often seriously consider surgery around 52–54.
   • Mentions “big aging ages” referenced as 44 and 66.
   • Claims older patients may get less predictable outcomes due to structural changes (including bone resorption affecting facial framework).

3. “Too early vs too late”

   • Doing things early doesn’t eliminate future options; repeat work is still possible for people who maintain aggressively.
   • Discusses “second round” possibility and suggests longevity may improve in some scenarios (e.g., connective tissue issues).

4. Connective tissue / “Erdanosa” / hypermobility

   • Describes collagen deficiency/spectrum condition (hypermobile connective tissue).
   • Example: a 43-year-old whose dermatologist testing suggested spectrum-related connective tissue concerns; more monitoring recommended.

5. Youngest facelift/neck lift examples

   • States he performed a neck lift on a 23-year-old (two days prior to recording).
   • States he performed a facelift at age 32.
   • Clarifies that an endoscopic/“endo facelift” is treated as a different category in his “full facelift” framing.

6. Endo facelift: generally discouraged for the host

   • The host says they would never allow an “endo facelift” (“no matter how much I begged”).
   • Rationale: anatomy and prior procedures (including fat grafting) could cause the endo approach to widen/bulk the midface.

7. Fat transfer (personal experience)

   • Host describes an early “roller-coaster” period:
     • After fat grafting (stomach fat injected into cheeks, under-eyes, temples), they were very swollen within 2 days.
     • Then they experienced dramatic fluctuations (“all the fat is gone” / “face is huge” / puffing back up).
   • Surgeon attributes improvements over time to technique changes.

8. Fat purification methods compared (main technical review)

   • Old school gauze rolling
     • Produces “okay” results but higher infection risk due to exposing sterile fat to an open table environment.
   • Centrifugation
     • Described as a gold standard for 10+ years.
     • Spins to separate fluids (less water/oil), but may not remove everything.
   • “Pure graft / puregraft” method (current approach described)
     • Uses a 70 nanometer filter to retain fat cells while allowing other components to pass.
     • Claimed benefits:
       • Volume cut roughly in half (e.g., 50 cc → ~20–25 cc)
       • Less swelling/fluctuation; more stability and potentially higher/longer-lasting yield
       • Concentrates “regenerative” cell content (described as stem-cell-like/ADSC richness)
     • Pros emphasized: less “crash out” and better bounce-back.
     • Cons/limitations: outcomes vary by person (no precise numbers provided).

9. Candidate selection: fat transfer vs Sculptra vs filler / “Renuva” types

   • Frames options on a spectrum:
     • Filler = immediate volume but can become “puffy”/showy
     • Bio-stimulators = stimulate tissue (e.g., Sculptra; “Renuva”; “hyperdil…” and “Rejuvel Life” mentioned)
     • Fat grafting = volume + cellular contribution; positioned for larger rejuvenation
   • Guidance:
     • Small localized softening/shadow issues → Sculptra
     • Larger hollows needing meaningful volume → fat grafting
     • “Renuva” described as creating fat (for appropriate cases)
     • Cautions about lumpy-bumpy risk with certain fine fat derivatives (nanofat/microfat) for particular concerns

10. Sculptra (“secret”) and surgeon stance

    • Surgeon says he loves Sculptra and disputes common anti-Sculptra skepticism.
    • Discusses concerns about collagen generation mechanics and potential “Velcro-like” tissue effects during dissection, but says it’s manageable with proper timing/healing intervals.
    • Host says they used less filler and leaned into Sculptra, perceiving better “sculpt” results.

11. Softwave (trend discussed, conditional endorsement)

    • Not universally recommended; depends on:
      • being the right candidate,
      • correct anatomy,
      • matching the underlying problem.
    • Surgeon suggests selection bias: people with bad experiences may be more likely to seek surgical consults.
    • Host anecdote: a trusted colleague used softwave on the neck with genuinely good contour.

12. Threads: described as a “funeral”/declining trend

    • Threads are portrayed as the procedure to “bury” or replace.
    • Reason given: people try to delay a facelift using multiple thread placements; surgeon implies threads aren’t a long-term substitute.

13. “Fox eyes” / “fairy nose” / overdone aesthetic trends

    • Hosts criticize trends that may look good in 2D photos but look weird/strange in 3D in real life.
    • Mentions “anything animal/feline” as a “no.”

14. Buckle fat removal: kept (with caveats)

    • Surgeon says he “keeps it” if the person fits selection criteria:
      • If there’s too much lower-face fullness, removal can improve contour now.
      • Long-term: volume will still be needed later either way, so planning matters.

15. Overdone vs underdone

    • Strong preference for underdone because it’s easier to tweak later.
    • Overdone is compared to “burnt toast” or “burning bridges” because it’s harder to reverse.

16. Laser resurfacing: a trend to resurrect

    • Says he’d “resurrect” laser resurfacing because it:
      • helps sun damage,
      • can clear precancerous cells.
    • Notes downtime: he recommends healing time (mentions 2–3 weeks every 2–3 years as an ideal referenced pattern).

17. PDRN / PDGF / exosomes / micro-needling claims

    • PDRN
      • Approved topically; injecting is not FDA-approved (per transcript).
      • Belief: builds collagen; some efficacy with microneedling; requires expectation management.
    • PDGF
      • Presented as derived growth factors from PRP/PRF.
      • Surgeon claims no good evidence for cosmetic injection use; possible risks noted (nodules/skin cancer concerns referenced).
      • Recommends sticking to PRF/PRP.
    • Exosomes
      • Not all exosomes are equal; delivery method matters.
      • RF microneedling can cauterize/drill without tunnel delivery → tends toward more topical improvement.
      • Traditional microneedling may do better for certain outcomes than RF exosome delivery.

18. Softwave cost/expected improvement skepticism

    • Criticism: minimally invasive procedures often quote vague “improvement” ranges like 10% to 40%.
    • Host questions whether that variability is worth spending about $5,000.

19. Chin implants: “under the radar” and small changes matter

    • Surgeon highlights chin implants as impactful with minimal visibility:
      • millimeter-level changes can transform the profile.
    • Approach: typically under-the-chin incision (described as lower infection risk than inside-mouth approach, per transcript).
    • Claims “no chin implant illness” due to placement under bone lining with less soft-tissue exposure.
    • Host is interested, but surgeon suggests it may not fit host’s body/allergies.

20. What procedure the host would never get

    • The host: endo facelift (explicit).
    • Surgeon supports that anatomy determines results; endo can widen the midface for some people and look bulky, especially with animation.

21. General perspective on social media driving surgery demands

    • 100% attributed to social media for younger patients seeking certain procedures (especially endoscopic facelift).
    • Warnings:
      • Fans may assume they can replicate a celebrity result by copying a procedure.
      • Anatomy and limitations still apply; plans must be individualized.
    • Older patients more often say: “I used to look like that.”

---

Pros (as Presented)

• Modern fat transfer purification may reduce swelling/fluctuation and improve yield/stability (per surgeon’s comparison).
• Maintenance-based approach supports longer-term planning.
• Sculptra/sculpt approach is described as improving skin quality and providing subtle volume/softening.
• Softwave can work well for correct candidates (example: neck contour).
• Laser resurfacing positioned as effective for longer-term skin benefits despite downtime.
• Chin implants described as high-impact with discreet, small changes.

---

Cons / Risks / Critiques (as Presented)

• Fat transfer early swelling can be intense and fluctuate (host “roller coaster”).
• Minimally invasive treatments may have variable outcomes and depend on body response (skepticism about the common 10–40% “improvement” framing).
• Threads framed as potentially inferior/short-term for delaying a true facelift.
• Some aesthetic trends (e.g., fox eyes/fairy nose) may look good in photos but can be off in real life (3D).
• PDGF / certain growth factor injections: surgeon says little evidence exists for cosmetic injection use; risks include nodules and other concerns.
• Social media may drive misaligned expectations and body-dysmorphia-like decision-making patterns.
• Overdone results are harder to fix; underdone is safer.

---

Comparisons Made

• Fat transfer techniques: gauze rolling vs centrifugation vs “puregraft” with 70 nm filtration.
• Procedure spectrum:
  • filler (immediate)
  • bio-stimulators (tissue/collagen stimulation)
  • fat grafting (volume + cellular contribution)
• Thread “alternative” vs facelift: threads described as a trend that doesn’t replace surgery well.
• Microneedling variants: traditional microneedling vs RF microneedling with exosomes (delivery differences affecting outcomes).
• Softwave vs expectations: surgeon highlights selection bias and outcome variability.

---

Ratings / Numerical Scores

• No formal star ratings or review scores.
• Discussed numerical range: minimally invasive “improvement” is often quoted as 10%–40% (context: softwave/related treatments), and the host mentions spending about $5,000.
• Ages mentioned for procedures:
  • Neck lift at 23
  • Facelift at 32
• Fat yield example:
  • 50 cc → ~20–25 cc after puregraft filtration (example used in discussion).

---

Verdict / Recommendation (Concise)

The discussion supports individualized maintenance: start with conservative, properly selected tweaks and reserve larger surgeries (facelift/neck lift) for the right anatomy and life stage. For fat transfer, the video favors modern purification (puregraft/70nm filtration) over older methods due to improved stability and yield. Trend treatments—especially threads and highly specific “photo-only” aesthetic targets (e.g., fox eyes/fairy nose)—are heavily cautioned against, particularly when social media expectations are driving decisions.

---

Speaker-Specific Views (At End)

• Dr. Miguel Mascaro (surgeon)

  • Emphasizes anatomy, long-term planning, and differences in evidence/technique (especially fat purification).
  • Recommends maintenance strategy and strongly cautions about social-media-driven expectations.
  • Conditionally supports softwave depending on candidate/anatomy.
  • Skeptical about PDGF injections and some exosome delivery methods.
  • Critical of threads and certain “photo-only” facial aesthetics (fox eyes).

• Ariel (host; patient/guest)

  • Shares lived experience with fat transfer, including swelling/fluctuation.
  • Explicitly rejects endo facelift for themselves.
  • Explains personal comfort/concerns about procedures and complications.
  • Questions the value of minimally invasive improvement ranges relative to cost.

---